Study treatments
Nintedanib was initiated at a dose of 150 mg orally BID, starting with the morning dose on the day after docetaxel administration days (Days 2–7, 9–14, and 16–28 in each 28-day cycle). The dose of nintedanib was increased to a maximum of 200 mg BID using a 3+3 dose escalation design (